Similar results were found in clinical setting, when ‘matched’ tumour and tumour-free colon tissues from the same patient showed significantly decreased KRAS4A/4B ratio in tumours harbouring both mutant and wild-type KRAS [76, 77]. This evidence concerns the gene KRAS and neoplasm.